Ezetimibe BE [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-09-30 15:26 (962 d 04:08 ago) – Posting: # 20657
Views: 3,408

Hi ElMaestro,

» "The applicant should document that the enzymatic de-conjugation can be considered quantitative under assay conditions"
»
» :-D:vomit:

That would be a valid request. Has to be determined in method development & validation. No big deal, since β-glucuronidase is used for decades.

Dif-tor heh smusma 🖖 [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,084 posts in 4,629 threads, 1,566 registered users;
online 6 (0 registered, 6 guests [including 4 identified bots]).
Forum time: Thursday 19:35 CEST (Europe/Vienna)

That which is not controversial
is of no particular interest.    Johann Wolfgang von Goethe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5